Clinical Study
Gastric Composite Tumor of Alpha Fetoprotein-Producing Carcinoma/Hepatoid Adenocarcinoma and Endocrine Carcinoma with Reference to Cellular Phenotypes
Table 3
Clinicopathologic features of AFP-producing carcinoma and neuroendocrine carcinoma of the stomach.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MANEC, mixed-adenoneuroendocrine carcinoma; LCNEC, large-cell neuroendocrine carcinoma; SCNEC, small-cell neuroendocrine carcinoma; AFPC, alfa fetoprotein-producing carcinoma; Site; U, upper-third; M, middle-third; L, lower-third of the stomach. Tub 1, well-differentiated tubular adenocarcinoma; Tub 2, moderately differentiated tubular adenocarcinoma; Pap, papillary adenocarcinoma; Por, poorly differentiated adenocarcinoma; DOD, died of disease. |